• OPEN AN ACCOUNT
Indian Indices
Sensex
81,028.02 1,718.01
( 2.17%)
Global Indices
Nasdaq
51,462.04 -82.02
(-0.16%)
Dow Jones
7,424.83 50.10
(0.68%)
Hang Seng
57,293.47 -3,784.43
(-6.20%)
Nikkei 225
10,662.59 -120.07
(-1.11%)
Forex
USD-INR
94.41 -0.18
(-0.19%)
EUR-INR
106.07 -0.23
(-0.22%)
GBP-INR
127.18 -0.23
(-0.18%)
JPY-INR
0.60 0.00
(-0.04%)

EQUITY - MARKET SCREENER

Tata Steel Ltd
Industry :  Steel - Large
BSE Code
ISIN Demat
Book Value()
500470
INE081A01020
137.5435247
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TATASTEEL
12.93
232193.61
EPS(TTM)
Face Value()
Div & Yield %
14.39
1
2.15
 

Bal Pharma consolidated net profit declines 33.89% in the March 2026 quarter
May 28,2026
Net profit of Bal Pharma declined 33.89% to Rs 3.59 crore in the quarter ended March 2026 as against Rs 5.43 crore during the previous quarter ended March 2025. Sales rose 2.69% to Rs 84.08 crore in the quarter ended March 2026 as against Rs 81.88 crore during the previous quarter ended March 2025.

For the full year,net profit declined 13.02% to Rs 6.28 crore in the year ended March 2026 as against Rs 7.22 crore during the previous year ended March 2025. Sales rose 2.83% to Rs 311.66 crore in the year ended March 2026 as against Rs 303.08 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales84.0881.88 3 311.66303.08 3
OPM %12.579.33 -10.249.75 -
PBDT6.284.77 32 17.0114.91 14
PBT3.222.59 24 5.935.14 15
NP3.595.43 -34 6.287.22 -13